SPAC1D4.05c Antibody

What is SPAC1D4.05c and why is it significant in fission yeast research?

SPAC1D4.05c refers to a specific gene/protein in Schizosaccharomyces pombe (strain 972/ATCC 24843) for which antibodies have been developed. The antibody recognizes the recombinant SPAC1D4.05c protein immunogen, making it valuable for researchers investigating gene expression and protein function in fission yeast. Current applications include ELISA and Western blotting techniques, with species reactivity specific to yeast .

The significance of SPAC1D4.05c in research stems from its potential role in understanding fundamental cellular processes in fission yeast. Similar to how researchers have developed antibodies against various proteins in other model organisms, antibodies against yeast proteins enable the investigation of protein-protein interactions, subcellular localization, and expression levels under different experimental conditions.

What experimental validation should be performed before using SPAC1D4.05c Antibody?

Thorough validation is critical before incorporating any antibody into experimental workflows. For SPAC1D4.05c Antibody, researchers should:

• Perform specificity testing using wild-type and knockout/deleted SPAC1D4.05c strains to confirm the antibody recognizes the intended target

• Conduct Western blot analysis to verify the antibody detects a protein of the expected molecular weight

• Test cross-reactivity against related proteins or in different yeast species

• Compare results with alternative detection methods (e.g., epitope tagging)

A structured validation approach similar to antibody validation in other systems should be employed, as demonstrated by the methodical characterization approaches used for therapeutic antibodies like Abrilumab and research antibodies against bacterial targets like SpA5 .

What are the optimal storage and handling conditions for maintaining SPAC1D4.05c Antibody activity?

Based on manufacturer specifications, the SPAC1D4.05c Antibody should be stored at -20°C or -80°C for long-term preservation of activity . For general polyclonal antibody handling:

Researchers should avoid repeated freeze-thaw cycles by preparing single-use aliquots, as protein degradation can significantly impact experimental reproducibility. When handling the antibody for experiments, maintain cold chain conditions and consider adding preservatives such as sodium azide (0.02%) for working stocks, though ensure compatibility with downstream applications.

What controls should be included when using SPAC1D4.05c Antibody in experiments?

Robust experimental design requires appropriate controls:

• Positive control: Lysate from wild-type S. pombe expressing SPAC1D4.05c

• Negative control:

  • Lysate from SPAC1D4.05c knockout strain

  • Pre-immune serum (provided with the antibody)

• Loading control: Antibody against a constitutively expressed yeast protein

• Secondary antibody only: To detect non-specific binding

• Blocking peptide competition: Using the recombinant immunogen protein/peptide provided with the antibody

When evaluating experimental results, always refer to these controls to ensure proper interpretation. The pre-immune serum included with the SPAC1D4.05c Antibody serves as a valuable negative control to assess background reactivity.

What methodological considerations are critical for optimizing Western blot protocols with SPAC1D4.05c Antibody?

Western blot optimization for SPAC1D4.05c Antibody requires careful attention to several parameters:

When extracting proteins from yeast cells, consider that cell wall disruption requires more vigorous methods than mammalian cells. The tough cell wall of S. pombe necessitates mechanical disruption with glass beads or enzymatic pre-treatment to ensure efficient protein extraction.

Based on patterns observed in antibody research, signal optimization may require adjusting transfer conditions for different sized proteins. For instance, similar to how custom transfer protocols were developed for analyzing complex antibody structures in the PLAbDab project , researchers may need to optimize transfer time and buffer composition for the specific molecular weight of SPAC1D4.05c.

How can epitope characterization be performed for SPAC1D4.05c Antibody?

Understanding the epitope(s) recognized by SPAC1D4.05c Antibody can provide valuable insights for experimental applications and interpretation:

• Peptide array analysis:

  • Synthesize overlapping peptides spanning the SPAC1D4.05c sequence

  • Probe the array with the antibody to identify reactive peptides

  • Map reactive peptides to the protein sequence

• Structural epitope mapping:

  • Generate protein fragments or domain-specific constructs

  • Express and purify these fragments

  • Test antibody reactivity against each fragment

• Computational prediction:

  • Apply methods similar to those used for SpA5 antibody epitope prediction

  • Use AlphaFold2 for protein structure prediction

  • Employ molecular docking to identify potential binding sites

• Mutagenesis approach:

  • Introduce point mutations at predicted epitope sites

  • Express mutant proteins and test antibody binding

  • Identify critical residues for antibody recognition

The epitope identification approach described for SpA5 antibodies using AlphaFold2 and molecular docking represents a modern computational strategy that could be adapted for SPAC1D4.05c Antibody characterization.

What strategies should be employed when troubleshooting inconsistent ELISA results with SPAC1D4.05c Antibody?

When facing inconsistent ELISA results, consider the following systematic troubleshooting approach:

• Reagent quality assessment:

  • Check antibody activity using dot blot

  • Test different antibody and antigen lots

  • Prepare fresh buffers and blocking solutions

• Protocol optimization:

  • Coating buffer composition (carbonate vs. phosphate)

  • Antigen concentration (0.5-10 μg/mL titration)

  • Blocking conditions (time, temperature, buffer composition)

  • Antibody dilution series (establish optimal concentration)

  • Incubation times and temperatures

• Data analysis considerations:

  • Establish proper positive and negative controls

  • Use statistical approaches to determine assay variability

  • Calculate signal-to-noise ratios

• Common interference factors:

  • Cross-reactivity with related yeast proteins

  • Non-specific binding to plate surfaces

  • Matrix effects from complex samples

ELISA optimization requires iterative testing and validation, similar to the approach used in characterizing therapeutic antibodies like Abrilumab biosimilar where multiple parameters were systematically evaluated to establish robust detection protocols.

How can researchers quantitatively assess cross-reactivity of SPAC1D4.05c Antibody with proteins from related yeast species?

Cross-reactivity assessment is crucial for determining antibody specificity:

• Preparation of lysates from various yeast species:

  • S. pombe (positive control)

  • S. cerevisiae (baker's yeast)

  • C. albicans (pathogenic yeast)

  • Other related fungi

• Quantitative Western blot analysis:

  • Normalize protein loading across species

  • Perform side-by-side blotting with consistent conditions

  • Quantify signal intensity ratios relative to S. pombe

• Competitive binding assays:

  • Pre-incubate antibody with purified SPAC1D4.05c protein

  • Test binding to lysates from different species

  • Calculate percent inhibition of binding

• Cross-reactivity evaluation metrics:

The cross-reactivity assessment approach mirrors techniques used in antibody characterization described in the Patent and Literature Antibody Database (PLAbDab) , where sequence identity and structural comparisons were employed to evaluate antibody specificity across related targets.

What advanced data analysis approaches should be used to resolve contradictory results when using SPAC1D4.05c Antibody in different experimental contexts?

When confronted with contradictory results across different experimental systems:

• Systematic variable isolation:

  • Document all experimental conditions (buffers, temperatures, incubation times)

  • Change one variable at a time to identify critical factors

  • Create a decision tree for troubleshooting

• Orthogonal validation approaches:

  • Confirm findings using alternative detection methods

  • Utilize epitope tagging or CRISPR modification of the target

  • Compare with transcript-level analysis (RT-PCR or RNA-seq)

• Statistical analysis of reproducibility:

  • Calculate intra- and inter-assay coefficients of variation

  • Perform power analysis to determine appropriate sample sizes

  • Apply appropriate statistical tests based on data distribution

• Multi-dimensional data integration:

  • Combine results from multiple antibody-based methods

  • Correlate with functional assays or phenotypic observations

  • Apply machine learning approaches for pattern recognition

• Advanced imaging analysis for localization studies:

  • Deconvolution microscopy for improved resolution

  • Co-localization analysis with known markers

  • Quantitative image analysis for signal distribution

Such comprehensive approaches to resolving contradictory results align with modern antibody research methodologies like those employed in high-throughput antibody characterization studies , where multiple analytical techniques were integrated to validate antibody performance.